Physician profile
Daron J Lind
NPI 1225288202
$928.40
in general payments reported to CMS, 2019-2025
10 companies · $91.87 in 2025
The $91.87 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $128 · 2021: $164 · 2022: $46.90 · 2023: $78.86 · 2024: $419 · 2025: $91.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.52 |
| Education | $263.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hu-Friedy Mfg. Co., LLC | $263.19 | 2024 | Hu-Friedy |
| Straumann USA LLC | $232.84 | 2021-2024 | |
| Dentsply Sirona INC | $184.53 | 2020-2025 | Tph Spectra Universal Composite Restorative Low Viscosity, Cavitron |
| Nobel Biocare USA | $89.57 | 2021-2023 | Nobelactive |
| Biolase, INC. | $46.90 | 2022 | |
| Kerr Corporation | $41.43 | 2020-2021 | |
| Voco America INC. | $26.68 | 2021-2025 | Admira Fusion X-Tra, Admira Protect, Bifix Qm |
| Henry Schein, INC. | $15.47 | 2025 | |
| Solventum Corporation | $15.00 | 2025 | Clarity Aligners |
| 3m Company | $12.79 | 2023 | 3m Relyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daron Lind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.